Does calendula help heal wounds and prevent radiation skin burns?

Calendula officinalis flowers contain several classes of compounds that work together to produce its skin-healing effects.

Triterpenoid esters — particularly faradiol monoester and faradiol diester — are the primary anti-inflammatory agents. They inhibit NF-κB, a master regulator of the inflammatory signaling cascade, and reduce production of TNF-alpha, IL-6, and prostaglandin E2. Research shows that 250–500 mg/kg oral doses of calendula extract produce 50–66% inhibition of carrageenan-induced paw edema in animal models, effects comparable to some pharmaceutical anti-inflammatories⁴.

Flavonoids — isorhamnetin, narcissin, and rutin — provide antioxidant protection and contribute to the anti-inflammatory effects through COX-2 inhibition. They also help explain calendula's antioxidant capacity in mucous membranes, which may be why it reduces radiation-induced oral mucositis⁵.

Carotenoids give the flowers their distinctive orange-yellow color and appear to contribute to wound repair by supporting collagen synthesis and skin regeneration.

Wound Healing and Tissue Repair

Calendula accelerates wound closure through multiple pathways. Animal studies demonstrate that topical calendula extract promotes angiogenesis (new blood vessel formation), enhances fibroblast activity, increases collagen deposition, and speeds the transition from the inflammatory to the proliferative phase of healing³. These are the mechanical prerequisites for good wound repair.

A systematic review of 14 studies — 7 animal experiments and 7 clinical trials — found consistent evidence of accelerated inflammation resolution and increased granulation tissue production in extract-treated groups across acute wound models. Two clinical studies on venous leg ulcers demonstrated meaningfully reduced ulcer surface area compared to controls².

Radiation Dermatitis: Clinical Trial Evidence

The strongest clinical evidence comes from a landmark 2004 Phase III randomized controlled trial in France¹. In 254 breast cancer patients receiving postoperative radiation therapy, calendula cream was compared to trolamine (a standard pharmaceutical option). Grade 2 or higher acute dermatitis occurred in 41% of the calendula group versus 63% of the trolamine group (P < 0.001). Patients on calendula also had significantly less radiation-induced pain and fewer interruptions to their radiotherapy schedule.

This is unusually strong evidence for a botanical product — a multicenter, prospective, Phase III trial with a pharmaceutical active comparator rather than placebo.

Oral Mucositis

A separate randomized controlled clinical study examined calendula extract mouthwash in 40 head and neck cancer patients undergoing chemoradiotherapy. Compared to placebo, patients in the calendula group had significantly lower oral mucositis severity at weeks 2, 3, and 6 (p < 0.048). The protective effect was attributed to the extract's flavonoid and phenolic content and its antioxidant capacity at mucosal surfaces⁵.

Practical Uses

Calendula is most commonly used topically as a cream, salve, oil infusion, or gel. For internal use, it can be taken as a tea (1–2 teaspoons of dried flowers per cup) or tincture.

Common applications with evidence support include:

• Minor wounds and cuts: topical cream or salve applied 2–3 times daily
• Skin irritation, rashes, or dry skin: calendula-infused oil or cream
• Minor burns and sunburn: cooling calendula gel
• Oral health: calendula mouthwash for gum inflammation or mouth sores
• Radiation burns (oncology setting): cream applied after each session, as in the clinical trial

Calendula is generally considered very safe, including for children and sensitive skin. It belongs to the Asteraceae family, so people with ragweed, chrysanthemum, or daisy allergies should use it with caution and test a small area first. Oral use is not recommended during pregnancy due to traditional use as a uterine stimulant, though topical use is widely considered safe.

See our Aloe Vera page for another well-studied topical skin herb. For internal inflammation, see Boswellia and Cat's Claw.

Radiation Dermatitis: Phase III Randomized Controlled Trial

Pommier et al. (2004) conducted a multicenter Phase III RCT in 254 patients who had undergone breast cancer surgery and were receiving postoperative radiation therapy (PMID 15084618). Between July 1999 and June 2001, patients were randomized to apply either calendula ointment or trolamine (Biafine) after each radiotherapy session to the irradiated field. The primary endpoint was incidence of grade 2 or higher acute dermatitis (defined per RTOG scale as moist desquamation or worse).

Results: grade 2+ dermatitis occurred in 41% of the calendula group versus 63% of the trolamine group (absolute risk reduction of 22 percentage points; P < 0.001). Secondary outcomes also favored calendula: less frequent radiotherapy interruption, significantly lower radiation-induced pain scores, and greater patient-reported ease of application. The authors concluded that calendula should be the preferred agent for preventing acute radiation dermatitis in postoperative breast irradiation. This study is notable for its design quality — multicenter, prospective, with an active pharmaceutical comparator — and remains the primary evidence cited by oncology integrative medicine programs for calendula use.

Systematic Review of Wound Healing

Givol et al. (2019) systematically reviewed the literature on Calendula officinalis extract as monotherapy for wound healing through April 2018, searching PubMed, EMBASE, Cochrane, CINAHL, and Scopus (PMID 31145533). Of 14 studies meeting inclusion criteria — 7 animal experiments and 7 clinical trials — acute wound healing studies consistently showed faster resolution of the inflammatory phase and increased granulation tissue production in extract-treated groups across five animal studies and one randomized clinical trial. In chronic wound studies, two controlled studies in venous leg ulcers demonstrated reduced ulcer surface area compared to controls. The review judged the overall evidence as moderate in quality, noting heterogeneity in extract preparations and application methods across studies. The authors called for standardized extract formulations and larger-scale trials.

Animal Model Wound Healing: Mechanisms

Parente et al. (2012) characterized wound healing in rat models using the ethanolic extract, dichloromethane fraction, and hexanic fraction of C. officinalis flowers grown in Brazil (PMID 22315631). The study used chorioallantoic membrane assays to evaluate angiogenic activity, and cutaneous wound models for macroscopic, morphometric, histopathologic, and immunohistochemical analysis. All fractions stimulated angiogenesis; the ethanolic extract also demonstrated significant anti-inflammatory and antibacterial activity. Histopathological analysis showed that extract-treated wounds had enhanced fibroplasia (fibroblast proliferation) and collagen organization during the proliferative phase. The authors concluded that C. officinalis acts positively on both the inflammatory and proliferative phases of wound repair, consistent with its empirical traditional use.

Anti-Inflammatory Mechanisms: In Vivo and In Vitro

Preethi et al. (2009) investigated the anti-inflammatory mechanisms of calendula flower extract using standard animal models and cell culture (PMID 19374166). In carrageenan-induced paw edema, oral administration of 250 mg/kg body weight produced 50.6% inhibition, and 500 mg/kg produced 65.9% inhibition. Dextran-induced edema was similarly suppressed. In macrophage culture stimulated with lipopolysaccharide, the extract significantly inhibited TNF-alpha production. The mechanism analysis pointed to COX-2 inhibition and suppression of pro-inflammatory cytokines as the primary pathways. This study is frequently cited to explain the molecular basis of calendula's clinical effects, though it used whole-flower extract rather than isolated compounds.

Oral Mucositis: Randomized Clinical Trial

Babaee et al. (2013) randomized 40 head-and-neck cancer patients undergoing radiotherapy or concurrent chemoradiotherapy to receive 2% calendula extract mouthwash or placebo (20 per group) (PMID 23497687). Oral mucositis was assessed weekly by a radiation oncologist and a dentist using the Oral Mucositis Assessment Scale (OMAS). At weeks 2, 3, and 6, mucositis intensity was significantly lower in the calendula group (p < 0.048 at all timepoints). The extract was high in flavonoids and phenolic compounds. No adverse events were attributed to the mouthwash. Limitations include the small sample size (n = 40) and single-center design. This study provides preliminary clinical support for calendula's use in oncology supportive care alongside the radiation dermatitis data.

Comprehensive Phytochemical and Pharmacological Review

Shahane et al. (2023) authored an updated review of the therapeutic potential of Calendula officinalis, published in Pharmaceuticals, covering research from the previous five years⁶. The review lists the plant's constituents — flavonoids, triterpenoids, glycosides, saponins, carotenoids, volatile oil, amino acids, steroids, sterols, and quinones — and links them to anti-inflammatory, anti-cancer, antihelminthic, antidiabetic, wound-healing, hepatoprotective, and antioxidant activities. It also describes the plant's traditional use for burns and for gastrointestinal, gynecological, ocular, and skin conditions, and discusses molecular mechanisms and recent clinical studies⁶.

Strength of Evidence

The evidence base for topical calendula is one of the stronger ones among botanical products, anchored by a legitimate Phase III RCT. For radiation dermatitis prevention, the evidence is strong and clinically relevant. For general wound healing and skin repair, the systematic review suggests moderate evidence — consistent animal and pilot human data, but lacking large-scale placebo-controlled RCTs for everyday applications like minor wounds and rashes. For oral mucositis, preliminary clinical support exists but the evidence remains at the exploratory stage. Safety is well-established; this is a herb with centuries of topical use and no significant toxicity in the literature. Overall, for topical use in appropriate contexts, calendula is a well-supported choice with an excellent safety profile.